CytomX Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference Transcript
We can get the session started. My name is Alec Stranahan. I'm an associate on Ying Huang's team at Bank of America Merrill Lynch covering large cap biotech. Today, I have the pleasure of introducing Dr. Sean McCarthy, President and CEO of CytomX. Welcome to the conference, Sean.
Well, we only have 15 minutes for this session. We are the last ones in this room. So I suppose we can take as much time as we need. Sean is going to run through some slides, and then we can open it up for Q&A.
Great. Thank you very much, and maybe I'll pop that here. A pleasure to be here. I'll take about 20 minutes actually to go through this material, if you don't mind. There's quite a lot to get through. The company's been very active and productive over the last 12 to 18 months.
So first and foremost, we are CytomX Therapeutics. We are -- we have been engaged in over the last several years really
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
